IVI's Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI's open-source model for assessing value in non-small cell lung cancer therapies. If you want to learn more about IVI's open-source approach to value assessment, this webinar is a great place to start. Click here to [...]
In an interview with the Journal of Clinical Pathways, IVI's Jennifer Bright and Mark Linthicum discuss how IVI is transforming value assessment. Read the transcript from the interview here.